FELLOWS DAVID A 4
4 · Terns Pharmaceuticals, Inc. · Filed Jun 14, 2024
Insider Transaction Report
Form 4
FELLOWS DAVID A
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-10+32,000→ 32,000 totalExercise: $6.99Exp: 2034-06-09→ Common Stock (32,000 underlying)
Footnotes (1)
- [F1]The option will vest in full on the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting following the date of grant.